BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3855648)

  • 1. Detection of the blastic crisis cell clone in chronic myeloid leukaemia.
    Löwenberg B; Hagemeijer A; Abels J
    Br J Haematol; 1985 Jan; 59(1):27-36. PubMed ID: 3855648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia: a study of 69 cases.
    Alimena G; Dallapiccola B; Gastaldi R; Mandelli F; Brandt L; Mitelman F; Nilsson PG
    Scand J Haematol; 1982 Feb; 28(2):103-17. PubMed ID: 6953563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different cell clones in bone marrow and spleen of a patient with chronic myelocytic leukemia (CML) in blastic phase.
    Olinici CD; Petrov L; Macavei I; Dobay O
    Cancer; 1978 Dec; 42(6):2707-9. PubMed ID: 282004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of cytogenetic findings of erythroid colonies derived from a Ph+ ALL patient: fundamental differences between Ph+ ALL and blastic phase CML.
    Abe R; Ishibashi T; Kimura H; Uchida T; Kariyone S
    Cancer Genet Cytogenet; 1985 Sep; 18(1):49-54. PubMed ID: 3861235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferon.
    Talpaz M; Trujillo JM; Hittelman WN; Keating MJ; Gutterman JU
    Br J Haematol; 1985 Aug; 60(4):619-24. PubMed ID: 3861194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant patterns of chromosome changes and myeloblast proliferation during the terminal phase of chronic myeloid leukemia.
    Gall JA; Boggs DR; Chervenick PA; Pan S; Fleming RB
    Blood; 1976 Mar; 47(3):347-53. PubMed ID: 1062222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized blastoma preceding blastic transformation in Ph1-positive chronic myelogenous leukaemia: morphological and cultural studies of the transformation event.
    Asano S; Sato N; Ueyama Y; Mori M; Sakurai M; Tamaoki K; Chiba S; Imamura Y; Kosaka K
    Scand J Haematol; 1980 Sep; 25(3):251-8. PubMed ID: 6936775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer; 1984 Dec; 54(11):2456-9. PubMed ID: 6594187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic study of myeloid and erythroid colonies in chronic myeloid leukaemia with stable Ph1 mosaicism.
    Cramer P; Vainchenker W; Brouet JC; Berger R
    Br J Haematol; 1987 Sep; 67(1):51-4. PubMed ID: 3478079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic evaluation of chronic myeloid leukemia.
    Moore MA; Mertelsmann R; Pelus LM
    Blood Cells; 1981; 7(2):217-36. PubMed ID: 6945881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation in chronic granulocytic leukaemia. Different blast cell clones in different anatomical sites.
    Vilpo JA; Klemi P; Lassila O; Schröder J; de la Chapelle A
    Acta Haematol; 1979; 62(5-6):247-50. PubMed ID: 121665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal culture and cytogenetics. Indicators of a variant of chronic myelogenous leukemia.
    Selvaggi S; Wolman SR; Bornstein S; Edinger F
    Cancer; 1984 Dec; 54(12):2956-8. PubMed ID: 6594190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal-phase chronic myelogenous leukemia: approaches to treatment.
    Allen SL; Coleman M
    Cancer Invest; 1985; 3(5):491-503. PubMed ID: 3902166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karyotype evolution and multilineage involvement of Philadelphia chromosome-positive clones in blastic transformation of two patients with chronic myelocytic leukemia.
    Sato Y; Kitano K; Tsunoda S; Yoshida M; Kajii E; Suda T; Sakamoto S; Motoyoshi K; Saito M; Miura Y
    Blood; 1988 Jun; 71(6):1561-7. PubMed ID: 3163504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of chronic myelogenous leukemia: clinical, morphologic, and cytogenetic features.
    Muehleck SD; McKenna RW; Arthur DC; Parkin JL; Brunning RD
    Am J Clin Pathol; 1984 Jul; 82(1):1-14. PubMed ID: 6588747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph1-positive chronic myeloid leukemia.
    Sadamori N; Gomez GA; Sandberg AA
    Blood; 1983 May; 61(5):935-9. PubMed ID: 6572536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal changes in chronic granulocytic leukemia in blastic transformation and during remission.
    Beltran G; Varela M
    Cancer; 1980 Oct; 46(7):1590-3. PubMed ID: 6932255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome analysis of isolated colony erythroblasts in chronic myelogenous leukaemia.
    Dainiak N; Liu A; Dewey MC; Kulkarni V
    Br J Haematol; 1984 Mar; 56(3):507-12. PubMed ID: 6582926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ph1-positive chronic myeloid leukaemia presenting in blastic crisis: report of 12 cases.
    Zaccaria A; Ruggero D; Guolo ML; Guarini A; Frezza R; Baccarani M; Tura S
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):383-91. PubMed ID: 282907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.